He has more than 30 uears of board, corporate, finance and accounting leadership, according to a news release shared with Becker’s. His past experience includes at Calyxt, Medtronic and Young America Holdings.
Mr. Koschak is replacing former SynerFuse CFO Dennis McFadden, who is retiring and will have an strategic advisory role with the company.
SynerFuse focuses on treating back pain associated with spinal fusion.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.